V
4.21
0.03 (0.76%)
| Penutupan Terdahulu | 4.18 |
| Buka | 4.26 |
| Jumlah Dagangan | 26,294 |
| Purata Dagangan (3B) | 190,047 |
| Modal Pasaran | 39,783,688 |
| Harga / Jualan (P/S) | 1.91 |
| Harga / Buku (P/B) | 238.54 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Nov 2025 |
| Margin Operasi (TTM) | -236.41% |
| EPS Cair (TTM) | -11.40 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -10.10% |
| Nisbah Semasa (MRQ) | 1.34 |
| Aliran Tunai Operasi (OCF TTM) | -53.66 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -32.56 M |
| Pulangan Atas Aset (ROA TTM) | -62.87% |
| Pulangan Atas Ekuiti (ROE TTM) | -1,546.58% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Verrica Pharmaceuticals Inc. | Bercampur | Menurun |
AISkor Stockmoo
2.0
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | 3.0 |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 2.00 |
|
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 44.90% |
| % Dimiliki oleh Institusi | 32.25% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| KIRBY JOHN J. | 5.12 | - | 3,536 | 18,104 |
| MANNING PAUL B | 5.12 | - | 4,126,142 | 21,125,847 |
| RIEGER JAYSON | 5.12 | - | 94,311 | 482,872 |
| ROSENBERG NOAH L. | 5.12 | - | 2,357 | 12,068 |
| ZAWITZ DAVID | 5.12 | - | 10,000 | 51,200 |
| Jumlah Keseluruhan Kuantiti Bersih | 4,236,346 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 21,690,092 | |||
| Purata Pembelian Keseluruhan ($) | 5.12 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| KIRBY JOHN J. | Pegawai | 25 Nov 2025 | Beli (+) | 3,536 | 5.12 | 18,104 |
| RIEGER JAYSON | Pegawai | 25 Nov 2025 | Beli (+) | 94,311 | 5.12 | 482,872 |
| MANNING PAUL B | Pengarah | 25 Nov 2025 | Beli (+) | 1,375,380 | 5.12 | 7,041,946 |
| MANNING PAUL B | Pengarah | 25 Nov 2025 | Beli (+) | 2,750,762 | 5.12 | 14,083,901 |
| ZAWITZ DAVID | Pegawai | 25 Nov 2025 | Beli (+) | 10,000 | 5.12 | 51,200 |
| ROSENBERG NOAH L. | Pegawai | 25 Nov 2025 | Beli (+) | 2,357 | 5.12 | 12,068 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |